scholarly article | Q13442814 |
P356 | DOI | 10.3109/00207454.2013.789513 |
P8608 | Fatcat ID | release_fgl2mj2yobc4jc63yix3vbbike |
P698 | PubMed publication ID | 23528011 |
P50 | author | Mridul Roy | Q85240335 |
P2093 | author name string | Hao Liu | |
Fa-Fa Tian | |||
P2860 | cites work | The nuclear RNase III Drosha initiates microRNA processing | Q24295234 |
Ribonuclease activity and RNA binding of recombinant human Dicer | Q24315047 | ||
MicroRNA genes are transcribed by RNA polymerase II | Q24562649 | ||
Asymmetry in the assembly of the RNAi enzyme complex | Q27860763 | ||
Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
Functional siRNAs and miRNAs Exhibit Strand Bias | Q27861038 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Epilepsy: contemporary perspectives on evaluation and treatment | Q28241339 | ||
Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) | Q28243974 | ||
Identification of hundreds of conserved and nonconserved human microRNAs | Q28257480 | ||
Surgery for seizures | Q28275323 | ||
Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage | Q28291855 | ||
Adult epilepsy | Q28304952 | ||
The evolution of gene regulation by transcription factors and microRNAs | Q29617552 | ||
Repression of protein synthesis by miRNAs: how many mechanisms? | Q29620361 | ||
Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects | Q30524857 | ||
Inhibitory RNA in epilepsy: research tools and therapeutic perspectives | Q34126428 | ||
Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b | Q34168627 | ||
Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. | Q34170732 | ||
A prospective study of the requirement for and the provision of epilepsy surgery in the United Kingdom | Q34197701 | ||
Socioeconomic variation in incidence of epilepsy: prospective community based study in south east England | Q34204865 | ||
Life expectancy in people with newly diagnosed epilepsy | Q34348765 | ||
MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. | Q34418730 | ||
MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response | Q34427432 | ||
Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures | Q34992471 | ||
Clinically important change in quality of life in epilepsy. | Q35468261 | ||
miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132 | Q35475193 | ||
Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation | Q35606143 | ||
The use of antiepileptic drugs--principles and practice | Q35865176 | ||
Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis | Q35962195 | ||
Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response | Q36192088 | ||
Gene expression profile in temporal lobe epilepsy | Q36778564 | ||
Adenosine as a neuromodulator in neurological diseases | Q36974004 | ||
Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells | Q37426965 | ||
Intracellular toll-like receptors | Q37719951 | ||
Epileptic seizures and spirit possession in Haitian culture: Report of four cases and review of the literature | Q37781202 | ||
The role of inflammation in epileptogenesis | Q38004250 | ||
Insights into inflammation and epilepsy from the basic and clinical sciences | Q38019256 | ||
Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus | Q38330929 | ||
Possible role of the innate immunity in temporal lobe epilepsy. | Q38514811 | ||
Engineering human mesenchymal stem cells to release adenosine using miRNA technology | Q39670945 | ||
Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy | Q39893640 | ||
Temporal profiles of age-dependent changes in cytokine mRNA expression and glial cell activation after status epilepticus in postnatal rat hippocampus. | Q42252596 | ||
MicroRNA-34a upregulation during seizure-induced neuronal death | Q42560262 | ||
Quality of life of people with epilepsy: a European study | Q43524508 | ||
Epilepsy in the developing world. | Q45974518 | ||
Adenosine kinase and ribokinase--the RK family of proteins | Q46534681 | ||
The epidemiology of epilepsy: the size of the problem | Q47205746 | ||
Complement activation in experimental and human temporal lobe epilepsy | Q48215408 | ||
Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. | Q48465634 | ||
Interleukin-1β and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy | Q48469394 | ||
Prolonged increase in rat hippocampal chemokine signalling after status epilepticus | Q48649560 | ||
Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. | Q54396512 | ||
Epilepsy | Q55899118 | ||
Mortality in epilepsy | Q56047944 | ||
Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence | Q57808296 | ||
Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-term, prospective, population-based cohort | Q58449920 | ||
P433 | issue | 9 | |
P304 | page(s) | 617-622 | |
P577 | publication date | 2013-05-09 | |
P1433 | published in | International Journal of Neuroscience | Q6051511 |
P1476 | title | MicroRNA-based therapy: a new dimension in epilepsy treatment | |
P478 | volume | 123 |
Search more.